Search page

A Regulatory Risk haplotype in HLA-DQ region regulates antigen presentation of monocyte in Type 2 inflammation in chronic rhinosinusitis with nasal polyps

A Study Conducted in the Environmental Exposure Chamber (EEC) to Assess Onset of Action of Combination of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Dymista) in the Treatment of Allergic Rhinitis Symptoms Compared to Placebo

A patient-centric approach to chronic rhinosinusitis with nasal polyps (CRSwNP): developing tools to improve disease management and outcomes

A step towards standardized Clinical Remission Criteria for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): insights from a real-life study

A study to assess the impact of nasal congestion on a subject’s perception of facial and head discomfort when exposed to allergen in an Environmental Exposure Chamber (EEC)

ANCHOR-1 and 2 Study Design: Replicate Phase 3 Randomised, Double-Blind, Placebo-Controlled Studies of the Efficacy and Safety of Depemokimab in Patients with Chronic Rhinosinusitis with Nasal Polyps

Advancing Nasal Polyp Pathology with AI: A Study on 2D to 3D Microscopic Visualization

Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)

An in vitro study of the impact of IL-17A and IL-22 on ciliogenesis in nasal polyps epithelium via the Hippo-YAP pathway

Anti-thymic stromal lymphopoietin CM326 for uncontrolled chronic rhinosinusitis with nasal polyps: a randomized, double-blind, placebo-controlled phase 1b/2a trial

Artificial intelligence-based pathological subtype diagnosis of nasal polyps: a multidimensional and micro-visualization study

Association Between Allergic Rhinitis and Nasal Septum Deviation in Children: Results from the ARHINASD Study

Association between Blood Eosinophil Counts, Nasal Cytology, and Serum Inflammatory Biomarkers in Patients with Severe Asthma. The BRISA STUDY

Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry

Biologics and rhinosinusitis with and without nasal polyps

Challenges in Biologics for Chronic Rhinosinusitis with Nasal Polyps

Characteristics of patients with chronic rhinosinusitis with nasal polyps and allergic rhinitis enrolled in the global AROMA registry

Chronic nasal obstruction

Chronic rhinosinusitis with nasal polyposis: an old problem with a new solution

Clinical Implication of Neutrophil Phenotypes in Chronic Rhinosinusitis With Nasal Polyps

Clinical Remission in Asthma and its Correlation with Nasal Comorbidities

Clinical and Treatment Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps by Treating Physician Specialty: Results from an EU Chart Review Study

Clinical effects of dupilumab in patients with rhinosinusitis, nasal polyposis, and severe uncontrolled asthma with t2 phenotype, after 12 months of treatment

Comparative Analysis of Nasal Secretions and Serum Biomarkers in House Dust Mite Allergy: Correlation with Symptoms and Skin Prick Test Results

Comparative Gene Expression Analysis in Blood Samples and Nasal Polyps during Dupilumab Treatment for CRSwNP

Correlation between subjective and objective parameters in house dust mite nasal allergen challenge

CosMx™ single cell spatial imaging identifies changes in spatial cell communication in chronic rhinosinusitis with nasal polyps following anti – IL-5 treatment

Demographic Features Of Allergic Rhinitis Patients and Effect of Nasal Corticosteroid Treatment

Diagnostic performance of IgE sensitization with Blomia tropicalis for prediction of positive nasal challenge test

Distribution of Baseline Type 2 Inflammation Characteristics in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Biologic Clinical Trials: A Comparative Assessment

Doxycycline therapy reduced local nasal inflammation and promoted wound healing after FESS in Chronic Rhinosinusitis patients

Dual biological therapy with dupilumab and ixekizumab in a patient with asthma, nasal polyposis, atopic dermatitis and psoriasis

Dual monoclonal antibody therapy in a patient with chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma: a case report and proteome analysis

Dupilumab Treatment is Associated with Clinical Improvement and a Shift towards a health-associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis

Dupilumab alleviates the abnormal differentiation of club cells induced by IL-13 in chronic rhinosinusitis with nasal polyps

Dupilumab treatment effectively reduces nasal type 2 cytokine production following acetylsalicylic acid provocation in N-ERD patients

Early Responders within One Month of Dupilumab Treatment for Chronic Rhinosinusitis with Nasal Polyps

Effect of Dupilumab on Radiological Remission in Patients with Chronic Rhinosinusitis with Nasal Polyp: A step Toward Clinical Remission

Effect of anti IL-5/IL-5Rα biological treatment on tissue eosinophil subpopulations in patients affected by Chronic Rhinosinusitis with Nasal Polyp

Effectiveness and Safety of Dupilumab in patients with chronic rhinosinusitis with nasal polyps After One Year of Therapy: Results from a real-world non-interventional study in Germany (ProGNOSE)

Effects of Dupilumab on Eosinophil Subpopulations and Inflammation in Chronic Rhinosinusitis with Nasal Polyps

Efficacy and safety of tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps overall and in patients with and without co-morbid asthma: results from the phase 3 WAYPOINT study

Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps

Efficacy of Omalizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps and Association with Local Immunoglobulin E

Emerging Biologic Use May Reduce the Need for Corticosteroid Treatment and Surgery for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in France, Germany, Italy, Spain and the UK

Endotype in nasal inflammatory diseases using minimally invasive sampling techniques

Enhanced Production of CEACAM5 And Its Association With Increased Plasma Cell Infiltration In Chronic Rhinosinusitis With Nasal Polyps

Enhanced Symptom Assessment Accuracy: Allergen Exposure Chambers vs. Nasal Allergen Challenges for Timothy Grass Pollen-Induced Allergic Rhinitis

Eosinophil-derived neurotoxin measured in nasal mucosal lining fluid (Nasosorption) is a promising type 2 biomarker in allergic rhinitis

Eosinophilic Chronic Rhinosinusitis with Nasal Polyps : Current Perspective

Eosinophilic diseases: from nasal polyposis, eosinophilic asthma to EGPA (Eosinophilic Vasculitis with PolyAngioitis), evaluation of possible biomarkers of disease evolution

Exhaled nitric oxide as a predictor of nasal polyp recurrence

Exploratory analysis of the gene expression of biomarkers found in nasal epithelial cells of patients with allergic and non-allergic rhinitis

Exploring oscillometry potential to evaluate nasal resistance: A Proof of Concept study

Exposure of nasal epithelial cells with pollen aerosols and coronavirus

Frequency of Long-Term Development of Nonsteroidal Anti-Inflammatory Drug (NSAID) Hypersensitivity in Patients who Underwent Nasal Polypectomy during Childhood

Hippo-YAP inhibits the autophagic degradation of Cyclin D1 in chronic rhinosinusitis with nasal polyps

Impact of SARS-CoV-2 on Patients with Nasal Polyposis: Are They Worse Off Now Than Before COVID-19?

Impact of lysosomotropic agents on human primary mast cells isolated from nasal polyps

Impact of nasal obstruction on sleep

Improved Quality of Life, Early Symptom Control and Reduced Surgery with Mepolizumab in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): Results from the SYNAPSE Study

Improvement in Olfactory Training for Postoperative Olfactory Dysfunction in Chronic Rhinosinusitis with Nasal Polyps

Initiation of dupilumab led to reduced use of corticosteroids and antibiotics over 12 months in patients with chronic rhinosinusitis with nasal polyps treated in US real world practice

Investigating the Role of Skin Prick and Specific IgE Tests in Nasal Provocation Test Outcomes for Allergic Rhinitis Diagnosis

Lack of correlation between aerosolized Fel d 1 concentration and nasal or respiratory response

Local allergic rhinitis in paediatric patients: prevalence and clinical outcomes in nasal allergen challenge

Local nasal inflammation and postoperative wound healing is improved by postoperative doxycycline therapy after FESS in Chronic Rhinosinusitis patients

Longitudinal Assessment of Dupilumab’s Therapeutic Effects in Chronic Rhinosinusitis with Nasal Polyps

Macrophages mediated impairment of inflammation resolution in nasal polyps

Measurement of eosinophilic and neutrophilic granule proteins and IgE antibodies in nasal mucosal lining fluid in allergic rhinitis – A pilot study

Mental health, sexual functionality, quality of life, and patient experiences with chronic rhinosinusitis with nasal polyps at UNIMEQ-ORL in Bogotá, Colombia, 2022-2024: a mixed-methods study

Minimal Invasive Endotyping in Nasal Inflammatory Disease

Nasal Allergen Challenges in the clinical setting: Experience of a centre

Nasal allergen challenge

Nasal and respiratory symptoms, functional features, and sensitization to platinum salts in platinum catalysts manufacturing workers

Nasal dysbiosis in children with allergic and non-allergic rhinitis

Nasal microbiome in allergic rhinitis

Nasal microbiome in chronic rhinosinusitis

Nasal obstruction in a 16-year-old footballer unresponsive to topical corticosteroids

Nasal obstruction in children: diagnosis and treatment

Nasal provocation test with Dermatophagoides farinae(DF) in allergic rhinitis

Nasal secretions as a useful tool for monitoring systemic and mucosal antibody responses induced by mRNA-based vaccination

Onset of Action (OOA) and Efficacy of Azelastine Hydrochloride 0.15% Nasal Spray (AZNS) on Allergy Symptoms in an Environmental Exposure Chamber (EEC) Compared to Placebo (PL) and Mometasone Furoate/Olopatadine Hydrochloride NS (MFONS)

Operational performance of the Nasal Provocation Test in determining the frequency of allergy to Blomia tropicalis in sensitized patients at an allergy center: A 5-year follow-up

PROMs Improvement Effects of Biologics in Chronic Rhinosinusitis with Nasal Polyps Patients: Real-life Experience

Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma Experience Early and Sustained Benefit with Depemokimab in the Randomised, Double-Blind, Parallel-Group, Replicate ANCHOR-1/2 Studies

Performance of 5 item and 22 item sino-nasal outcome tests in response to dupilumab in chronic rhinosinusitis with nasal polyps

Pharmacokinetics and Pharmacodynamics following repeat dosing of ARS-1 (adrenaline nasal spray) versus intramuscular injection during induced allergic rhinitis: sub-analysis

Platycodon D protects human nasal epithelial cells from pyroptosis through the Nrf2/HO-1/ROS signaling cascade in chronic rhinosinusitis

Postoperative Anti-IgE Therapy for Chronic Rhinosinusitis with Nasal Polyps and Asthma: Efficacy and Prognostic Factors

Proteomic analysis identifies patients with chronic rhinosinusitis with nasal polyps who are responders and non-responders to benralizumab (NAPPREB study)

REALITI-N: First Ambidirectional Cohort Study Evaluating Real-World Mepolizumab Use in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Real-Life Effectiveness of Mepolizumab and Omalizumab in Sever Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Prospective Study

Real-Life Effectiveness of Monoclonal Antibody Therapy in Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Prospective Study

Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years

Real-world effectiveness of dupilumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) is independent of comorbidities, sinus surgery history and level of type 2 inflammation: Findings from CHRINOSOR

Role of nasal cytology in patients with bronchial asthma

SNOT-22 and olfactory perception in Chronic Rhinosinusitis with Nasal Polyps: A Retrospective Observational Study

Sequence of improvements in objective and patient-reported outcomes with dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: Analysis of the SINUS-52 study

Site-specific proteomics reveals key molecular features underlying the transition to nasal polyps

Spatial Pathology of Nasal Polyp Inflammation

Stapokibart for severe uncontrolled chronic rhinosinusitis with nasal polyps: multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 trial

Stratification Value of Nasal Brushing Arachidonate 15-Lipoxygenase in Stapokibart (CM310) Treatment for Patients with Seasonal Allergic Rhinitis: Results from MERAK

Tezepelumab reduces OCS use and improves sino-nasal symptoms in OCS-dependent patients with severe asthma and comorbid chronic rhinosinusitis (overall and with nasal polyps): results from the phase 3b WAYFINDER study

The Clinical Characteristics and Inflammatory Endotypes of Chronic Rhinosinusitis with Nasal Polyps in Southern China: A Multi-Center, Cross Section study

The Effect of Nasal Budesonide Irrigation in Patients With Anosmia and Hyposmia

The Influence of Dupilumab on the Nasal and Gastrointestinal Microbiome in Diffuse Type 2 Chronic Rhinosinusitis

The Relationship Between Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Serum Mas-Related G-Protein Coupled Receptor-X2 (MRGPRX2) Level

The Role of Rho GTPase Signaling on Epithelial-Mesenchymal Transition and Inflammation of Chronic Rhinosinusitis with Nasal Polyp

The correlation between chronic rhinosinusitis with/without nasal polyp and chronic kidney disease: a longitudinal follow-up study

The impact of secretory IgA on nasal microbiome control and its link to the development of chronic rhinosinusitis

The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood

The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps

The successful resolve of nasal polyps in patient with dupilumab treatment

Treatment of severe atopic dermatitis in pediatric patients with Dupilumab and effects of therapy on nasal and skin microbiota: preliminary experimental evidence

Understanding and managing Chronic Rhinosinusitis with Nasal Polyps

Unveiling the Prevalence and Impact of Silent Rhinovirus Infection in Chronic Rhinosinusitis with Nasal Polyps

Use of nasal irrigation as add on therapy to non responders to pharmacotherapy in chronic adenoiditis

131 genetic loci highlight immunological pathways and tissues in asthma and nasal polyposis

Assessment of local nasal IgE in patients with suspected dual allergic rhinitis before and after nasal allergen provocation – presentation of 6 cases

Association between olfactory function, nasal polyp score, nasal obstruction and quality of life in CRSwNP patients treated with dupilumab

Chacterisation of long-term nasal decongestant users and structured withdrawal of the nasal decongestant

Clinical Effectiveness of Tezepelumab on Upper and Lower Airway Symptoms in Patients with Asthma and Co-morbid Nasal Polyposis

Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of tezepelumab in adult patients with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT)

Difficult nasal breathing: differential diagnosis between mechanical and inflammatory nasal obstruction

Dupilumab Restores Barrier Function of Nasal Epithelial Cells and Decreases Type-2 Inflammatory Markers in Chronic Rhinosinusitis with Nasal Polyps

Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions

Evaluation of Early Real-World Efficacy and Safety of Mepolizumab in Chronic Rhinosinusitis with Nasal Polyposis Through a Multidisciplinary Approach

Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis

Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology

Nasal patency measurements: what do they learn us about nasal obstruction

Nasal polyp CD62Llow eosinophils as a prognostic biomarker of chronic rhinosinusitis with nasal polyp severity and predictive biomarker of mepolizumab and dupilumab response

Occupational sensitisation to Chrysonilia sitophila in an asthmatic patient with nasal polyposis

Omalizumab Efficacy in Relapse of Nasal Polyposis

Real-Life effectiveness of a Cohort of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) and Concomitant Moderate Persistent Asthma Treated with Dupilumab

SLC27A2 marks lipid peroxidation in nasal epithelial cells driven by type 2 inflammation in chronic rhinosinusitis with nasal polyps

Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment

The impact of intranasal corticosteroids on exhaled nitric oxide in chronic eosinophilic rhinosinusitis with nasal polyposis after surgery

The role of anosmia in predicting biologic responsiveness for Chronic Rhinosinusitis with Nasal Polyposis

Use of dupilumab in two pregnant women with nasal polyposis and severe persistent asthma: two case reports

Clinical improvement with mepolizumab after endoscopic nasal polyposis surgery in a patient with polyposis

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website

Only match titles

What are you looking for?

Knowledge Hub

Event Resources

Position Papers

Covid-19

Sponsored Symposia

Guidelines

Website

Sessions